NCT05796518Completed
Feasibility of a Patient Directed Tool to Assess Heart Health Among Endometrial Cancer Survivors
A Pilot Study to Examine Feasibility of a Patient Directed Tool to Assess Heart Health Among Endometrial Cancer Survivors
Source: ClinicalTrials.gov · Last updated 28 Mar 2025
Brief summary (registry, in English)
Investigators are conducting this study to find out more about what heart health means to participants and how healthcare providers can best help to manage heart health. Participants will be asked to view an electronic tool designed to promote heart health awareness and help to manage heart health outside of the clinic. This study will provide important information to help investigators develop future programs that improve cancer patient's heart health after they complete their treatment.
- Status (registry)
- Completed
- Study type
- Interventional
- Enrollment
- 44 (actual)
- First submitted
- 21 Mar 2023
- Start date
- 7 Sept 2023
- Primary completion date
- 7 Jun 2024
- Lead sponsor
- Wake Forest University Health Sciences
- Diseases
- Endometrial cancer
- NCT number
- NCT05796518
What you commit to
- Study type: Interventional
- Participants enrolled: 44
- From 7 Sept 2023 to the primary completion date, 7 Jun 2024
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Currently receiving treatment (e.g. radiation, chemotherapy, immunological treatments for endometrial cancer)
Other illness
- Have a history of endometrial cancer recurrence
Other
- Enrolled in hospice care or documentation of life expectancy \< 6 months
Who the study is looking for
- Scheduled for a routine surveillance visit for pathologically confirmed stages I-IV endometrial cancer
- Greater than or equal to 3 months post-potentially curative cancer treatment
- Patients must be at least 18 years of age
- Have a working email address
- Comfortable reading medical information in English, as per self-report
Age in the registry: 18 years to - · Sex: Female · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Wake Forest Baptist Comprehensive Cancer Center Coordinator of this site? Confirm its status | Winston-Salem | United States | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.